In clinical trials over 12 months, Circadin® has been administered at 5 mg daily doses without significantly changing the nature of the adverse reactions reported1. There are reports in the literature of the administration of daily doses of up to 300 mg melatonin without causing clinically significant adverse reactions1. No case of Circadin® overdose has been reported1. If overdose of Circadin® occurs, drowsiness is to be expected1. Clearance of the active substance is expected within 12 hours of ingestion1. No special treatment is required1.
Posted in: Dosing and administration